Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

The Canadian producer will sell flower through GROW Group under Spectrum Therapeutics, extending its European medical cannabis business.

Revenue is climbing and losses are narrowing, but dilution, cash burn and U.S. uncertainty continue to weigh on CGC shares.